Clear Street’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.66K Hold
8,876
﹤0.01% 984
2025
Q4
$6.3K Hold
8,876
﹤0.01% 811
2025
Q3
$6.66K Hold
8,876
﹤0.01% 709
2025
Q2
$7.77K Hold
8,876
﹤0.01% 529
2025
Q1
$6.66K Buy
8,876
+7,947
+855% +$6.04K ﹤0.01% 403
2024
Q4
$816 Buy
+929
New +$607 ﹤0.01% 500

Other funds holding OACCW

Clear Street's OACCW Position: Q1 2026 in Review

Clear Street held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 8,876 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #984.

Clear Street first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.77K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Clear Street held 8,876 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $6.66K as of Q1 2026.
  • Clear Street left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #984 holding.
  • Clear Street first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
  • Clear Street's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $7.77K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.